RIZZONE, Mario Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 4.444
EU - Europa 3.001
AS - Asia 1.301
SA - Sud America 90
OC - Oceania 71
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.936
Nazione #
US - Stati Uniti d'America 4.326
CN - Cina 745
IT - Italia 661
SE - Svezia 354
DE - Germania 304
IE - Irlanda 304
FR - Francia 248
GB - Regno Unito 206
FI - Finlandia 146
UA - Ucraina 146
JP - Giappone 143
ES - Italia 108
PL - Polonia 108
KR - Corea 107
CA - Canada 101
NL - Olanda 91
AT - Austria 87
VN - Vietnam 69
IN - India 67
AU - Australia 66
BR - Brasile 57
BE - Belgio 54
TR - Turchia 44
TW - Taiwan 39
CH - Svizzera 35
PT - Portogallo 21
RU - Federazione Russa 20
AR - Argentina 18
SG - Singapore 17
BG - Bulgaria 15
GR - Grecia 15
MX - Messico 15
DK - Danimarca 14
CL - Cile 13
HK - Hong Kong 13
RO - Romania 12
CZ - Repubblica Ceca 10
SN - Senegal 10
UZ - Uzbekistan 10
IL - Israele 9
IR - Iran 7
MY - Malesia 6
EG - Egitto 5
EU - Europa 5
IS - Islanda 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PH - Filippine 5
SI - Slovenia 5
TH - Thailandia 5
BY - Bielorussia 4
HU - Ungheria 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
CY - Cipro 3
HR - Croazia 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
BN - Brunei Darussalam 2
EC - Ecuador 2
EE - Estonia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MA - Marocco 2
MD - Moldavia 2
MT - Malta 2
SA - Arabia Saudita 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
GH - Ghana 1
GL - Groenlandia 1
ID - Indonesia 1
MN - Mongolia 1
MU - Mauritius 1
PK - Pakistan 1
SV - El Salvador 1
Totale 8.936
Città #
Chandler 587
Beijing 414
Dublin 298
Fairfield 235
Ashburn 203
Torino 199
Houston 184
Redwood City 161
Wilmington 151
Ann Arbor 144
Woodbridge 124
Villeurbanne 121
Nyköping 120
Seattle 111
Medford 110
Princeton 108
Jacksonville 102
Dearborn 101
Cambridge 97
Warsaw 80
Vienna 79
Pisa 66
Milan 53
Dong Ket 51
Boston 47
Shanghai 38
Boardman 34
Madrid 34
Guangzhou 30
Turin 30
New York 28
Hangzhou 27
Taipei 27
Tokyo 25
Seoul 20
Chengdu 19
Fremont 19
London 18
Ottawa 18
Rome 18
Toronto 18
Brussels 16
Norwalk 16
São Paulo 16
Duncan 15
Helsinki 15
Nanjing 15
San Diego 15
Verona 15
Edinburgh 14
Düsseldorf 13
Hebei 13
Lachine 13
Amsterdam 12
Jinan 12
Santiago 12
Changsha 11
Chongqing 11
Huntington Station 11
Saint Paul 11
Wuhan 11
Barcelona 10
Chicago 10
Groslay 10
Hamburg 10
Hartlepool 10
Istanbul 10
Melbourne 10
Paris 10
Buenos Aires 9
Cincinnati 9
Gent 9
Mumbai 9
Trento 9
Fuzhou 8
Hefei 8
Minneapolis 8
Napoli 8
Phoenix 8
Polska 8
Pune 8
Renton 8
Sydney 8
Valencia 8
Zhengzhou 8
Zurich 8
Baton Rouge 7
Essen 7
Mountain View 7
Oxford 7
Silver Spring 7
Singapore 7
Würzburg 7
Ankara 6
Berlin 6
Falls Church 6
Göttingen 6
Hanover 6
Nijmegen 6
Plano 6
Totale 4.928
Nome #
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. 683
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 641
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 605
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience 423
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. 323
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 304
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? 253
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. 250
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? 241
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients 241
Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease 218
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 206
Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges 144
Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. 143
Analisi dei costi della stimolazione cerebrale profonda (DBS) nella malattia di Parkinson: uno studio osservazionale su pazienti italiani. 135
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 132
The dominant-subthalamic nucleus phenomenon in bilateral deep brain stimulation for Parkinson's disease: Evidence from a gait analysis study 100
Neurological comorbidity and severity of COVID-19 98
Deep brain stimulation of subthalamic nucleus: behavioral modifications and familiar relations 90
ARGUMENTS IN FAVOUR OF AN EARLIER APPLICATION OF STN-DBS IN THE COURSE OF PARKINSON DISEASE. 87
Unilateral and bilateral subthalamic nucleus stimulation in Parkinson's disease: effects on EMG signals of lower limb muscles during walking 86
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 86
Deep brain stimulation in Parkinson's disease: comparison of pre- and post-operative neuropsychological evaluation 80
Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes 79
3 years comparison between duodopa and Deep Brain Stimulation 78
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 77
Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. 76
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 75
Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. 74
Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological and outcome correlations with the effects of stimulation 72
Transdermal rotigotine in dihydropteridine reductase deficiency 71
Effect of L-dopa and subthalamic nucleus stimulation on arm and leg swing during gait in Parkinson's Disease. 70
Apomorphine SC treatment in parkinsonian patients with long-term L-dopa syndrome during L-dopa drug holiday. 70
Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson's disease. 70
Beyond Nine Years of Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease 69
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 67
Continuous intraduodenal L-dopa/carbidopa gel infusion improves nocturnal sleep in advanced Parkinson’s disease 65
The dominant subthalamic nucleus: A gait analysis study 63
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 63
Deep brain stimulation of the subthalamic nucleus: Clinical effectiveness and safety 63
Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease. 62
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 61
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 61
Effects of subthalamic nucleus stimulation and L-dopa in trunk kinematics of patients with Parkinson's disease. 60
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up. 58
Clinical efficacy of different stimulation frequencies on dyskinesias and dystonias in subthalamic nucleus deep brain stimulation patients with parkinson's disease 58
Genetic background and outcome of Deep Brain Stimulation in Parkinson's disease 58
Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? 58
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 58
Effects of 80 Hz stimulation on gait in STN-DBS treated PD patients 57
Endovascular Treatment for Acute Ischemic Stroke 57
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters. 56
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 56
COVID-19 and Parkinson's Disease: What We Know So Far? 55
RELAZIONE TRA TARGETING ANATOMICO E NEUROFISIOLOGICO DEL NUCLEO SUBTALAMICO NELLA CHIRURGIA DELLA MALATTIA DI PARKINSON. 54
La stimolazione elettrica ad alta frequenza del nucleo subtalamico nel trattamento chirurgico della malattia di Parkinson. 54
High-frequency electrical stimulation of the subthalamic nucleus in Parkinson's disease: kinetic and kinematic gait analysis 51
Quantitative analysis of gait in Parkinson's disease: a pilot study on the effects of bilateral sub-thalamic stimulation. 51
Deep brain stimulation of the subthalamic nucleus: selection of patients and clinical results 51
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 51
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 51
A new index to assess turning quality and postural stability in patients with Parkinson's disease 50
Peripheral neuropathy in Parkinson’s disease patients treated with duodenal levodopa/carbidopa infusion: A clinical and electrophysiological follow-up study 49
Home monitoring of motor fluctuations in Parkinson’s disease patients 48
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 48
Nocturnal problems and sleep benefit in Parkinson’s disease. 47
Tuning Deep Brain Stimulation related depression by frequency modulation: a case report 47
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 47
Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-dopa treatment in Parkinson's disease 45
Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. 45
COVID-19 in Parkinson's disease: Report on prevalence and outcome 45
Onset of Covid-19 with impaired consciousness and ataxia: a case report 44
A man with hyponatremia, confusion, and involuntary limb movements 43
Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease 42
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 42
Parkinson's clinical features after 30 years of disease: A study from patients treated by subthalamic nucleus stimulation 40
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease 40
Malattia di Parkinson 39
Neurological comorbidities and COVID-19-related case fatality: A cohort study 38
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report 38
STIMOLAZIONE CEREBRALE PROFONDA DEL NUCLEO SUBTALAMICO : FOLLOW-UP NEUROPSICOLOGICO. 37
Efficacy of subthalamic nucleus stimulation for tremor dystonia: A case report 37
Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson's disease 36
Impact of subthalamic nucleus stimulation on the initiation of gait in Parkinson's disease 36
I movimenti involontari: tremori e distonie 36
Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study 35
Management dei principali effetti collaterali della DBS con esempi di casi DBS problemativi 34
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 34
Prospective assessment of peripheral neuropathy in duodopa treated patients 33
Levodopa-Induced Neuropathy: A Systematic Review 32
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection 30
Social Cognition deficits in Amyotrophic Lateral Sclerosis: a pilot cross-sectional population-based study 27
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 18
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 17
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells 6
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease 2
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 1
Totale 9.237
Categoria #
all - tutte 22.234
article - articoli 0
book - libri 0
conference - conferenze 2.440
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019412 0 0 0 0 0 0 0 0 0 107 204 101
2019/20201.251 52 64 85 146 124 145 156 117 131 93 83 55
2020/20211.132 107 141 96 58 82 98 67 75 112 92 75 129
2021/20221.205 66 40 54 99 69 45 51 60 41 109 290 281
2022/20231.778 202 165 60 171 147 410 111 119 162 62 109 60
2023/2024635 92 131 40 57 63 94 33 70 17 38 0 0
Totale 9.237